Arcellx (Arcellx) FCF Margin % : 83.86% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Arcellx FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Arcellx's Free Cash Flow for the three months ended in Dec. 2023 was $53.0 Mil. Arcellx's Revenue for the three months ended in Dec. 2023 was $63.1 Mil. Therefore, Arcellx's FCF Margin % for the quarter that ended in Dec. 2023 was 83.86%.

As of today, Arcellx's current FCF Yield % is 6.63%.

The historical rank and industry rank for Arcellx's FCF Margin % or its related term are showing as below:

ACLX' s FCF Margin % Range Over the Past 10 Years
Min: 168.73 Med: 168.73 Max: 168.73
Current: 168.73

During the past 5 years, the highest FCF Margin % of Arcellx was 168.73%. The lowest was 168.73%. And the median was 168.73%.

ACLX's FCF Margin % is ranked better than
98.75% of 1037 companies
in the Biotechnology industry
Industry Median: -147.18 vs ACLX: 168.73

Arcellx FCF Margin % Historical Data

The historical data trend for Arcellx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcellx FCF Margin % Chart

Arcellx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

168.73

Arcellx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial										-	1,010.84	-208.66	-120.54	83.86

Competitive Comparison of Arcellx's FCF Margin %

For the Biotechnology subindustry, Arcellx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arcellx's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arcellx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Arcellx's FCF Margin % falls into.

Arcellx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Arcellx's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	186.145	/	110.319
	=	168.73 %

Arcellx's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	52.955	/	63.148
	=	83.86 %

Arcellx FCF Margin % Related Terms

Thank you for viewing the detailed overview of Arcellx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arcellx (Arcellx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arcellx Inc (NAS:ACLX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

25 West Watkins Mill Road, Suite A, Gaithersburg, MD, USA, 20878

Website

https://www.arcellx.com

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Executives

Michelle Gilson	officer: Chief Financial Officer	25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG MD 20878
Christopher Heery	officer: Chief Medical Officer	C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM NC 27701
Rami Elghandour	director, officer: See Remarks	15 BARCELONA CIR, REDWOOD CITY CA 94065
Jill Carroll	director	C/O APPLIED GENETIC TECHNOLOGIES CORP., 11801 RESEARCH DRIVE, SUITE D, ALACHUA FL 32615
Sr One Capital Fund I Aggregator Lp	10 percent owner	C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD CA 92011
Scott D Sandell	10 percent owner
Forest Baskett	10 percent owner
Mohamad Makhzoumi	10 percent owner	2855 SAND HILL ROAD, MENLO PARK CA 94025
Florence Anthony A. Jr.	10 percent owner	5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815
New Enterprise Associates 15, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Olivia C Ware	director	11726 SAN VICENTE BLVD, SUITE 650, LOS ANGELES CA 90049
Novo Holdings A/s	10 percent owner	TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Sr One Capital Management, Llc	10 percent owner	985 OLD EAGLE SCHOOL ROAD, SUITE 511, WAYNE PA 19087
Sr One Co-invest Ii Manager, Llc	10 percent owner	985 OLD EAGLE SCHOOL ROAD, SUITE 511, WAYNE PA 19087
Nea Partners 15, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093